West Pharmaceutical Services Pre-Paid Expenses 2010-2025 | WST

West Pharmaceutical Services pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • West Pharmaceutical Services pre-paid expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • West Pharmaceutical Services pre-paid expenses for 2024 were $0B, a 0% decline from 2023.
  • West Pharmaceutical Services pre-paid expenses for 2023 were $0B, a 0% decline from 2022.
  • West Pharmaceutical Services pre-paid expenses for 2022 were $0B, a 0% decline from 2021.
West Pharmaceutical Services Annual Pre-Paid Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
West Pharmaceutical Services Quarterly Pre-Paid Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.149B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30